Literature DB >> 25839046

Inducing gene expression by targeting promoter sequences using small activating RNAs.

Ji Wang1, Robert F Place1, Victoria Portnoy1, Vera Huang1, Moo Rim Kang1, Mika Kosaka1, Maurice Kwok Chung Ho2, Long-Cheng Li1,3.   

Abstract

Vector-based systems comprised of exogenous nucleic acid sequences remain the standard for ectopic expression of a particular gene. Such systems offer robust overexpression, but have inherent drawbacks such as the tedious process of construction, excluding sequences (e.g. introns and untranslated regions) important for gene function and potential insertional mutagenesis of host genome associated with the use of viral vectors. We and others have recently reported that short double-stranded RNAs (dsRNAs) can induce endogenous gene expression by targeting promoter sequences in a phenomenon referred to as RNA activation (RNAa) and such dsRNAs are termed small activating RNAs (saRNAs). To date, RNAa has been successfully utilized to induce the expression of different genes such as tumor suppressor genes. Here, we describe a detailed protocol for target selection and dsRNA design with associated experiments to facilitate RNAa in cultured cells. This technique may be applied to selectively activate endogenous gene expression for studying gene function, interrogating molecular pathways and reprogramming cell fate.

Entities:  

Keywords:  RNAa; gene regulation; saRNA; transcriptional activation

Year:  2015        PMID: 25839046      PMCID: PMC4379447          DOI: 10.14440/jbm.2015.39

Source DB:  PubMed          Journal:  J Biol Methods        ISSN: 2326-9901


  46 in total

1.  E-cadherin intron 2 contains cis-regulatory elements essential for gene expression.

Authors:  Marc P Stemmler; Andreas Hecht; Rolf Kemler
Journal:  Development       Date:  2005-01-26       Impact factor: 6.868

2.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

3.  dbEST--database for "expressed sequence tags".

Authors:  M S Boguski; T M Lowe; C M Tolstoshev
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

Review 4.  Enhancing the efficiency of transgene expression.

Authors:  A J Clark; A L Archibald; M McClenaghan; J P Simons; R Wallace; C B Whitelaw
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1993-02-27       Impact factor: 6.237

5.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

6.  Poly(dA-dT) promoter elements increase the equilibrium accessibility of nucleosomal DNA target sites.

Authors:  J D Anderson; J Widom
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

7.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles.

Authors:  Mark E Davis; Jonathan E Zuckerman; Chung Hang J Choi; David Seligson; Anthony Tolcher; Christopher A Alabi; Yun Yen; Jeremy D Heidel; Antoni Ribas
Journal:  Nature       Date:  2010-03-21       Impact factor: 49.962

8.  Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy.

Authors:  Mikko P Turunen; Tiia Lehtola; Suvi E Heinonen; Genet S Assefa; Petra Korpisalo; Roseanne Girnary; Christopher K Glass; Sami Väisänen; Seppo Ylä-Herttuala
Journal:  Circ Res       Date:  2009-08-20       Impact factor: 17.367

9.  A status report on RNAi therapeutics.

Authors:  Akshay K Vaishnaw; Jared Gollob; Christina Gamba-Vitalo; Renta Hutabarat; Dinah Sah; Rachel Meyers; Tony de Fougerolles; John Maraganore
Journal:  Silence       Date:  2010-07-08

10.  DBTSS: database of transcription start sites, progress report 2008.

Authors:  Hiroyuki Wakaguri; Riu Yamashita; Yutaka Suzuki; Sumio Sugano; Kenta Nakai
Journal:  Nucleic Acids Res       Date:  2007-10-16       Impact factor: 16.971

View more
  9 in total

1.  Enhancing DPYSL3 gene expression via a promoter-targeted small activating RNA approach suppresses cancer cell motility and metastasis.

Authors:  Changlin Li; Wencong Jiang; Qingting Hu; Long-Cheng Li; Liang Dong; Ruibao Chen; Yinghong Zhang; Yuzhe Tang; J Brantley Thrasher; Chang-Bai Liu; Benyi Li
Journal:  Oncotarget       Date:  2016-04-19

2.  RNA activating-double stranded RNA targeting flt-1 promoter inhibits endothelial cell proliferation through soluble FLT-1 upregulation.

Authors:  Susie Choi; Hironori Uehara; Yuanyuan Wu; Subrata Das; Xiaohui Zhang; Bonnie Archer; Lara Carroll; Balamurali Krishna Ambati
Journal:  PLoS One       Date:  2018-03-06       Impact factor: 3.240

3.  Upregulation of E‑cadherin expression mediated by a novel dsRNA suppresses the growth and metastasis of bladder cancer cells by inhibiting β-catenin/TCF target genes.

Authors:  Chuanchang Li; Jiaxuan Liu; Qingsong Zhang; Kai Cui; Qiangqiang Ge; Chenghe Wang; Zhong Chen
Journal:  Int J Oncol       Date:  2018-03-29       Impact factor: 5.650

4.  Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.

Authors:  Wen Jiang; Dandan Zhu; Chenghe Wang; Yu Zhu
Journal:  Cancer Med       Date:  2020-12-01       Impact factor: 4.452

5.  Small activating RNA activation of ATOH1 promotes regeneration of human inner ear hair cells.

Authors:  Yong-Li Zhang; Moorim Kang; Jian-Cheng Wu; Meng-Yao Xie; Ruo-Yan Xue; Qi Tang; Hua Yang; Long-Cheng Li
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

6.  RNA aptamers specific for transmembrane p24 trafficking protein 6 and Clusterin for the targeted delivery of imaging reagents and RNA therapeutics to human β cells.

Authors:  Dimitri Van Simaeys; Adriana De La Fuente; Serena Zilio; Alessia Zoso; Victoria Kuznetsova; Oscar Alcazar; Peter Buchwald; Andrea Grilli; Jimmy Caroli; Silvio Bicciato; Paolo Serafini
Journal:  Nat Commun       Date:  2022-04-05       Impact factor: 17.694

7.  Targeted Induction of Endogenous VDUP1 by Small Activating RNA Inhibits the Growth of Lung Cancer Cells.

Authors:  Ki Hwan Park; Jeong-Wook Yang; Joo-Hee Kwon; Hyunju Lee; Yeo Dae Yoon; Byeong Jo Choi; Myeong Youl Lee; Chang Woo Lee; Sang-Bae Han; Jong Soon Kang
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

Review 8.  Aptamer-iRNAs as Therapeutics for Cancer Treatment.

Authors:  Mario M Soldevilla; Daniel Meraviglia-Crivelli de Caso; Ashwathi P Menon; Fernando Pastor
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-18

Review 9.  Small Activating RNAs: Towards the Development of New Therapeutic Agents and Clinical Treatments.

Authors:  Hossein Ghanbarian; Shahin Aghamiri; Mohamad Eftekhary; Nicole Wagner; Kay-Dietrich Wagner
Journal:  Cells       Date:  2021-03-08       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.